Search for: "Novartis Inc., c/o Novartis Corp"
Results 1 - 20
of 50
Sort by Relevance
|
Sort by Date
9 Nov 2022, 1:00 pm
Corp. v. [read post]
20 May 2022, 10:26 am
Corp. v. [read post]
19 Mar 2022, 2:09 pm
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
12 Dec 2021, 2:22 pm
Novartis Pharms. [read post]
5 Aug 2021, 2:22 pm
C&O Enters., Inc., 773 F.2d 151, 153–54 (7th Cir. 1985). [read post]
13 Jan 2018, 8:00 pm
American Home Products Corp. [read post]
3 Mar 2016, 5:19 am
Novartis Pharmaceuticals Corp., 247 P.3d 244, 257 (Mont. 2010); Downing v. [read post]
24 Aug 2015, 5:00 am
Abbott Laboratories, Inc., ___ F. [read post]
26 May 2015, 7:42 am
The ideal defendant’s case might occur in several ways: similar biomarker evidence would point a finger at a purely genetic cause or at some other (perhaps voluntary or non-anthropogenic) exposure; or, a person exposed to a toxin known to cause the person's disease in susceptible people might have a gene that completely neutralized the toxic effect and also might lack a biomarker that is uniformly found in people whose disease was caused by exposure.Steve C. [read post]
9 Apr 2015, 5:00 am
Novartis Pharmaceuticals Corp., 2011 WL 1533467, at *9-10 (E.D.N.Y. [read post]
7 Nov 2014, 5:52 am
Novartis Pharmaceuticals Corp., 952 F. [read post]
23 Jun 2014, 12:57 pm
Sox, Michael C. [read post]
22 May 2014, 5:00 am
” Id. at §20.1(c). [read post]
9 Jan 2014, 1:37 pm
Central Garden & Pet Corp., 891 F. [read post]
5 Sep 2013, 12:24 pm
Novartis Pharmaceutical Corp., 2013 WL 4648449 (M.D. [read post]
5 Jul 2013, 5:00 am
Novartis Consumer Health, Inc., 55 Cal. [read post]
25 Nov 2011, 5:00 am
O’Charley's Inc., 683 S.E.2d 728, 738 (N.C. [read post]
15 Sep 2011, 5:00 am
Genzyme Corp., ___ Fed. [read post]
27 Aug 2011, 7:55 pm
P. 56(c). [read post]
15 Jun 2011, 4:56 am
IntelliPharmaCeutics Corp. et al. [read post]
